Trial on Treatment With Inhaled Furosemide of Preterm and Term Neonates With Transient Tachypnoea

• Status: Completed
• Trial end date: 2015-07-01
• Target enrollment: 0
• Participant gender: All

Summary

In this study we will prospectively analyze the benefit of inhaled furosemide for preterm and term neonates with Transient Tachypnoea.

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: University of Cologne
• Treatments: Furosemide

Criteria

Inclusion Criteria:

• Neonates with 35+0-39+0 GA on the first day of life with the clinical diagnosis of Transient Tachypnoea

• The need for CPAP >6 h to obtain the oxygen saturation >92%

• Written informed consent of parent/guardian

Exclusion Criteria:

• Systemic infection

• Intubation and mechanical ventilation before Inclusion in the trail

• Malformation and any other several disease with disturb of respiratory

• Subjects participating in other clinical trials